BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

339 related articles for article (PubMed ID: 15243159)

  • 21. Natural killer T cells recognize diacylglycerol antigens from pathogenic bacteria.
    Kinjo Y; Tupin E; Wu D; Fujio M; Garcia-Navarro R; Benhnia MR; Zajonc DM; Ben-Menachem G; Ainge GD; Painter GF; Khurana A; Hoebe K; Behar SM; Beutler B; Wilson IA; Tsuji M; Sellati TJ; Wong CH; Kronenberg M
    Nat Immunol; 2006 Sep; 7(9):978-86. PubMed ID: 16921381
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Glycolipids and phospholipids as natural CD1d-binding NKT cell ligands.
    Tsuji M
    Cell Mol Life Sci; 2006 Aug; 63(16):1889-98. PubMed ID: 16794785
    [TBL] [Abstract][Full Text] [Related]  

  • 23. CD1d-mediated antigen presentation to natural killer T (NKT) cells.
    Brutkiewicz RR; Lin Y; Cho S; Hwang YK; Sriram V; Roberts TJ
    Crit Rev Immunol; 2003; 23(5-6):403-19. PubMed ID: 15030309
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Structural characterization of mycobacterial phosphatidylinositol mannoside binding to mouse CD1d.
    Zajonc DM; Ainge GD; Painter GF; Severn WB; Wilson IA
    J Immunol; 2006 Oct; 177(7):4577-83. PubMed ID: 16982895
    [TBL] [Abstract][Full Text] [Related]  

  • 25. CD1 expression and CD1-restricted T cell activity in normal and tumour-bearing human liver.
    Kenna T; O'Brien M; Hogan AE; Exley MA; Porcelli SA; Hegarty JE; O'Farrelly C; Doherty DG
    Cancer Immunol Immunother; 2007 Apr; 56(4):563-72. PubMed ID: 16924493
    [TBL] [Abstract][Full Text] [Related]  

  • 26. The CD1 system: antigen-presenting molecules for T cell recognition of lipids and glycolipids.
    Porcelli SA; Modlin RL
    Annu Rev Immunol; 1999; 17():297-329. PubMed ID: 10358761
    [TBL] [Abstract][Full Text] [Related]  

  • 27. A role for CD1d-restricted NKT cells in injury-associated T cell suppression.
    Faunce DE; Gamelli RL; Choudhry MA; Kovacs EJ
    J Leukoc Biol; 2003 Jun; 73(6):747-55. PubMed ID: 12773507
    [TBL] [Abstract][Full Text] [Related]  

  • 28. The bovine CD1 family contains group 1 CD1 proteins, but no functional CD1d.
    Van Rhijn I; Koets AP; Im JS; Piebes D; Reddington F; Besra GS; Porcelli SA; van Eden W; Rutten VP
    J Immunol; 2006 Apr; 176(8):4888-93. PubMed ID: 16585584
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Natural killer T cells restricted by the monomorphic MHC class 1b CD1d1 molecules behave like inflammatory cells.
    Mempel M; Ronet C; Suarez F; Gilleron M; Puzo G; Van Kaer L; Lehuen A; Kourilsky P; Gachelin G
    J Immunol; 2002 Jan; 168(1):365-71. PubMed ID: 11751982
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Crystal structure of mouse CD1d bound to the self ligand phosphatidylcholine: a molecular basis for NKT cell activation.
    Giabbai B; Sidobre S; Crispin MD; Sanchez-Ruìz Y; Bachi A; Kronenberg M; Wilson IA; Degano M
    J Immunol; 2005 Jul; 175(2):977-84. PubMed ID: 16002697
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Mechanism of CD1d-restricted natural killer T cell activation during microbial infection.
    Brigl M; Bry L; Kent SC; Gumperz JE; Brenner MB
    Nat Immunol; 2003 Dec; 4(12):1230-7. PubMed ID: 14578883
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Chewing the fat on natural killer T cell development.
    Godfrey DI; McConville MJ; Pellicci DG
    J Exp Med; 2006 Oct; 203(10):2229-32. PubMed ID: 17000869
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Cross-presentation of disialoganglioside GD3 to natural killer T cells.
    Wu DY; Segal NH; Sidobre S; Kronenberg M; Chapman PB
    J Exp Med; 2003 Jul; 198(1):173-81. PubMed ID: 12847141
    [TBL] [Abstract][Full Text] [Related]  

  • 34. CD1d and natural killer T cells in immunity to Mycobacterium tuberculosis.
    Arora P; Foster EL; Porcelli SA
    Adv Exp Med Biol; 2013; 783():199-223. PubMed ID: 23468111
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Interplay of cytokines and microbial signals in regulation of CD1d expression and NKT cell activation.
    Sköld M; Xiong X; Illarionov PA; Besra GS; Behar SM
    J Immunol; 2005 Sep; 175(6):3584-93. PubMed ID: 16148102
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Regulation of CD1d expression by murine tumor cells: escape from immunosurveillance or alternate target molecules?
    Fiedler T; Walter W; Reichert TE; Maeurer MJ
    Int J Cancer; 2002 Mar; 98(3):389-97. PubMed ID: 11920590
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Nonclassical CD1d-restricted NK T cells that produce IL-13 characterize an atypical Th2 response in ulcerative colitis.
    Fuss IJ; Heller F; Boirivant M; Leon F; Yoshida M; Fichtner-Feigl S; Yang Z; Exley M; Kitani A; Blumberg RS; Mannon P; Strober W
    J Clin Invest; 2004 May; 113(10):1490-7. PubMed ID: 15146247
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Cutting edge: Compartmentalization of Th1-like noninvariant CD1d-reactive T cells in hepatitis C virus-infected liver.
    Exley MA; He Q; Cheng O; Wang RJ; Cheney CP; Balk SP; Koziel MJ
    J Immunol; 2002 Feb; 168(4):1519-23. PubMed ID: 11823474
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Development and function of CD1d-restricted NKT cells: influence of sphingolipids, SAP and sex.
    Sandberg JK; Ljunggren HG
    Trends Immunol; 2005 Jul; 26(7):347-9. PubMed ID: 15925541
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Regulation of antitumour immunity by CD1d-restricted NKT cells.
    Swann J; Crowe NY; Hayakawa Y; Godfrey DI; Smyth MJ
    Immunol Cell Biol; 2004 Jun; 82(3):323-31. PubMed ID: 15186264
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 17.